Equity Compensation Through Stock Acquisition Rights for Directors
First written in FY2017-Q2. 5 of 9 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「Shares after vesting End of previous consolidated fiscal year ― ― Vesting 38,400 12,000 Exercise 38,400 12,000 Forfeiture ― ― Unexercised balance ― ―」
For the stock acquisition rights for directors issued in 2016 and 2017, a total of 50,400 shares were exercised, leaving no unexercised balance at the end of the fiscal year. - 2026-06-03Cited as achievedGeneral Meetings of Shareholders
「Overview of the stock acquisition rights, etc. held by the company's officers at the end of the fiscal year, and the number of holders」
For stock acquisition rights granted to directors, the company discloses the remaining details as of 31 March 2026: 1,090 2016 stock acquisition rights representing 436,000 shares, and 350 2017 stock acquisition rights representing 140,000 shares. - FY2022AdvancedAnnual report
「Other (exercise of stock acquisition rights) 60,800 43」
During the fiscal year, 60,800 shares underlying stock acquisition rights for directors were exercised, adding a record of the plan's operation. - FY2021AdvancedAnnual report
「Shares after vesting End of previous consolidated fiscal year ― ― Vesting 114,000 26,000 Exercise 114,000 26,000」
For the stock acquisition rights for directors issued in 2016 and 2017, a total of 140,000 shares were exercised. The unvested balances are 293,200 shares and 98,000 shares, respectively. - FY2019AdvancedAnnual report
「Exercise 28,800 12,000」
For the stock acquisition rights for directors issued in 2016 and 2017, 28,800 shares and 12,000 shares, respectively, were exercised, for a total of 40,800 shares, leaving no unexercised balance. - FY2018RestatedAnnual report
「3 August 2017」
The disclosure continues to cover the stock option plan, including the 2017 Stock Acquisition Rights for 10 directors. The number of underlying shares for the 2017 grant is 70,000, and the exercise period is from 23 August 2017 to 22 August 2047. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows: LEC,INC. 2017 Stock Acquisition Rights.」
The Company newly issued the 2017 Stock Acquisition Rights, which may be exercised after the holder ceases to hold office as a director. The number of stock acquisition rights is 350, the number of underlying shares is 70,000, and the exercise period is from 23 August 2017 to 22 August 2047. - FY2017RestatedAnnual report
「The Company has adopted a stock option plan using stock acquisition rights.」
The disclosure continues to cover the 2016 Stock Acquisition Rights for 10 directors. The number of underlying shares is 109,000, the exercise period is from 23 August 2016 to 22 August 2046, and ¥173 million in share-based compensation expense was recognized during the consolidated fiscal year. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows: LEC,INC. 2016 Stock Acquisition Rights. Number of stock acquisition rights: 1,090; number of shares underlying the stock acquisition rights: 109,000; payment upon exercise: ¥1; exercise period: 23 August 2016 to 22 August 2046.」
The Company issued the 2016 Stock Acquisition Rights during the second quarter accounting period. The disclosure states that they may be exercised after the holder ceases to hold office as a director, and newly discloses them as a share-based compensation plan for directors.